Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Injection Related Anxiety In Insulin-treated Diabetes.

A. Zambanini, R. Newson, M. Maisey, M. Feher
Published 1999 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The presence of injection related anxiety and phobia may influence compliance, glycaemic control and quality of life in patients with insulin-treated diabetes. Unselected consecutive, insulin-treated patients attending a diabetes clinic for follow-up, completed a standardised questionnaire providing an injection anxiety score (IAS) and general anxiety score (GAS). A total of 115 insulin-treated (80 Type 1 and 35 Type 2) diabetic patients completed the questionnaire. Injections had been avoided secondary to anxiety in 14% of cases and 42% expressed concern at having to inject more frequently. An IAS > or = 3 was seen in 28% of patients and of these, 66% injected insulin one to two times/day, 45% had avoided injections, and 70% would be bothered by more frequent injections. A significant correlation between IAS and GAS was seen (Kendall's tau-a 0.30, 95% CI 0.19-0.41, P < 0.001). GAS was significantly associated with both previous injection avoidance and expressed concern at increased injection frequency. No significant correlation was seen with HbA1c and injection or general anxiety scores. Symptoms relating to insulin injection anxiety and phobia have a high prevalence in an unselected group of diabetic patients requiring insulin injections and are associated with higher levels of general anxiety.
This paper references
10.1111/j.1600-0447.1983.tb09716.x
The Hospital Anxiety and Depression Scale
A. Zigmond (1983)
10.1016/0022-3999(95)00515-3
Mood, learned resourcefulness and perceptions of control in type 1 diabetes mellitus.
R. White (1996)
10.1056/NEJM199309303291401
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus
D. Nathan (1993)
10.1177/014572179602200105
Knowledge about hypoglycemia in young women with type I diabetes and their supportive others.
J. Drass (1996)
10.1002/(SICI)1096-9136(199704)14:4<321::AID-DIA356>3.0.CO;2-H
Needle Phobia in Type 1 Diabetes Mellitus
A. Zambanini (1997)
10.1016/0005-7967(91)90067-D
Acquisition of blood and injection phobia and anxiety response patterns in clinical patients.
Lars-Göran Öst (1991)
10.1097/00005053-198612000-00005
Psychiatric Illness in Diabetes Mellitus: Relationship to Symptoms and Glucose Control
P. Lustman (1986)
The psychological condition of a cohort of Nigerian diabetic subjects.
Akinlade Ks (1996)
10.2337/diacare.20.4.585
Levels and Risks of Depression and Anxiety Symptomatology Among Diabetic Adults
M. Peyrot (1997)
10.2337/diacare.20.3.292
NIDDM Patients' Fears and Hopes About Insulin Therapy: The basis of patient reluctance
L. Hunt (1997)
10.1111/j.1651-2227.1996.tb14192.x
Psychological reactions at the onset of insulin‐dependent diabetes mellitus in children and later adjustment and metabolic control
G. Thernlund (1996)
10.5860/choice.33-1827
Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.
D. Washington (1994)
10.1016/0168-8227(96)01198-9
Psychological status of diabetic people with or without lower limb disability.
A. Carrington (1996)
10.2337/diacare.20.2.176
Phobic Symptoms, Particularly the Fear of Blood and Injury, Are Associated With Poor Glycemic Control in Type I Diabetic Adults
I. Berlin (1997)
10.2307/2090408
A new asymmetric measure of association for ordinal variables.
R. H. Somers (1962)



This paper is referenced by
10.7759/cureus.9364
A Review of the Impact of Smoking on Inhaled Insulin: Would You Stop Smoking if Insulin Can Be Inhaled?
P. Malhotra (2020)
10.1046/j.1464-5491.2001.00547.x
Phobia of self‐injecting and self‐testing in insulin‐treated diabetes patients: opportunities for screening
E. Mollema (2001)
10.1186/s12889-018-5064-y
The role of hypoglycemia in the burden of living with diabetes among adults with diabetes and family members: results from the DAWN2 study in The Netherlands
G. Nefs (2018)
Insulin Injection and Finger Sticking Fear in People with Diabetes
R. Pınar (2014)
10.1007/S11892-007-0026-2
The new diabetes inhalers: New tools for the clinician
W. Cefalu (2007)
10.3810/pgm.2012.09.2587
Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens
D. Oyer (2012)
A BITTERSWEET EXISTENCE: THE LIVED EXPERIENCES OF FOUR YOUNG WOMEN WITH DIABETES MELLITUS
K. Walker (2008)
10.1210/jc.2012-1763
Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
M. Testa (2012)
10.11606/T.60.2009.TDE-01062009-142902
Avaliação das preferencias dos pacientes por atributos de risco/benefício do tratamento insulínico no diabetes: um modelo de escolha discreta
Camila Guimarães (2009)
10.3329/ICPJ.V1I2.9447
Diabetes mellitus: A journey of insulin
D. T. Akhter (2012)
10.1016/j.diabres.2011.02.002
Barriers to diabetes management: patient and provider factors.
Soohyun Nam (2011)
10.2337/DIACARE.23.6.765
Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation.
E. Mollema (2000)
10.1097/NMC.0b013e3181fc6093
Needle Anxiety in Children With Type 1 Diabetes and Their Mothers
C. Howe (2011)
10.1517/17425247.5.8.915
Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence
A. Pfützner (2008)
10.1517/17425247.5.9.1047
Delivery of insulin to the buccal mucosa utilizing the RapidMist™ system
G. Bernstein (2008)
10.1016/j.jpsychores.2012.11.013
Association of diabetes with anxiety: a systematic review and meta-analysis.
K. Smith (2013)
10.2337/DIACARE.27.1.162
Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.
K. Hermansen (2004)
10.12968/BJON.2009.18.18.44550
Type 1 diabetes: identifying and evaluating patient injection technique.
Jennifer Spray (2009)
10.1586/17434440.6.2.115
FlexPen® for the delivery of insulin: accuracy, injection force and patient preference
A. Pfützner (2009)
10.1089/dia.2009.0041
Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
Angel Comulada (2009)
10.1177/14746514060060030201
Review: Inhaled insulin: overcoming barriers to insulin therapy?
S. Bellary (2006)
10.2337/dc17-S006
3. Comprehensive Medical Evaluation and Assessment of Comorbidities
(2016)
10.1111/j.1464-5491.2008.02538.x
Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London
H. Khan (2008)
10.1111/j.1365-2648.2011.05853.x
Psychological resistance to insulin therapy in adults with type 2 diabetes: mixed-method systematic review.
Huey-Fen Wang (2012)
PSYCHIATRIC AND PSYCHOSOCIAL ISSUES AMONG INDIVIDUALS LIVING WITH DIABETES
J. S. Gonzalez (2017)
10.1016/j.mayocp.2016.06.010
New Insulin Delivery Recommendations.
A. Frid (2016)
10.1111/jan.13818
The fear of needles: A systematic review and meta‐analysis
Jennifer McLenon (2019)
Type 1 Diabetes in Adults
S. Jabbour (2010)
Новые рекомендации по контролю и лечению дислипидемии, а также профилактике сердечно-сосудистых заболеваний
О О Мартышин (2017)
10.1185/030079906X132703
Inhaled insulins: the present and future of diabetes therapy
Stefano Del Prato (2006)
10.1177/014572170302900309
Addressing Dosing Frequency in Diabetes: A Simple Approach to Improving Adherence to Therapy and Clinical Outcomes
A. Morris (2003)
10.1056/NEJMP068294
Finding new treatments for diabetes--how many, how fast... how good?
D. Nathan (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar